Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Reporter Papua New Guinea.
Press releases published on August 12, 2025
AgEagle Aerial Systems Announces New RedEdge-P Green Camera to Advance Precision Agriculture
GlobeNewswire
·
August 12, 2025
Ground-breaking RedEdge-P Green camera to provide revolutionary accuracy for smart farming WICHITA, Kan., Aug. 12, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS), a leading provider of advanced drone and aerial imaging solutions, …
UPONLY Launches Beta Testing Phase – $25,000 Bug Bounty, 30,000+ Users In, 1,000 USDC Test Credits Per Account!
GlobeNewswire
·
August 12, 2025
Munich, Germany, Aug. 12, 2025 (GLOBE NEWSWIRE) -- UPONLY, the revolutionary trading platform powered by the first token that can only go up, has officially launched its Beta Testing Phase – and it’s already making waves with over 30,000 active users …
Genius Group Seeks Dual Listing in Asia
GlobeNewswire
·
August 12, 2025
SINGAPORE, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that on August 8th, 2025, the Company’s Board of Directors …
BioXcel Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Updates
GlobeNewswire
·
August 12, 2025
Topline data from SERENITY At-Home Phase 3 trial for acute treatment of agitation associated with bipolar disorders or schizophrenia expected in August FDA meeting scheduled in August and is intended to support potential sNDA submission for label expansion …
Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights
GlobeNewswire
·
August 12, 2025
Data from Phase 3 Orbit and Cosmic studies of setrusumab in osteogenesis imperfecta expected around year-end 2025 Cash of $56.1 million as of June 30, 2025, expected to support operations into 2027 LONDON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Mereo BioPharma …
Global Regenerative Medicine Market Set to Triple, Reaching $49.0 Billion by 2028 | MarketsandMarkets™.
GlobeNewswire
·
August 12, 2025
Delray Beach, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The global regenerative medicine market, valued at US$13.5 billion in 2022, stood at US$16.0 billion in 2023 and is projected to advance at a resilient CAGR of 25.1% from 2023 to 2028, culminating in a …
ZenaTech Reports Over 500% Increase in Year-Over-Year Revenue for Second Quarter of 2025 and Over 250% Increase in Revenue for the First Six Months of Year
GlobeNewswire
·
August 12, 2025
VANCOUVER, British Columbia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology business solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), …
Milestone Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Regulatory and Corporate Update
GlobeNewswire
·
August 12, 2025
FDA Accepted the Company’s Response to the CRL for CARDAMYST™ (etripamil) Nasal Spray; New PDUFA Target Date of December 13, 2025 Milestone Strengthens Balance Sheet to Fully Commercialize CARDAMYST if Approved Public Offering Raised Total Gross Proceeds …
Copyleaks Ranks No.153 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
GlobeNewswire
·
August 12, 2025
NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future, today announced that Copyleaks is No. 153 on the annual Inc. 5000 list, the most prestigious ranking of …
Zenas BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
GlobeNewswire
·
August 12, 2025
- Topline results from pivotal Phase 3 INDIGO trial in Immunoglobulin G4-Related Disease expected around year-end 2025 - - Completed enrollment of Phase 2 MoonStone trial in Relapsing Multiple Sclerosis; results expected early in the fourth quarter 2025 - …
insightsoftware Recognized on the 2025 Inc. 5000 List of Fastest-Growing Private Companies in America
GlobeNewswire
·
August 12, 2025
RALEIGH, N.C., Aug. 12, 2025 (GLOBE NEWSWIRE) -- insightsoftware, the most comprehensive provider of solutions for the Office of the CFO, today announced that for the second consecutive year, it has been named to the Inc. 5000 list. The annual list …
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025
GlobeNewswire
·
August 12, 2025
Advancing a broad, potential best-in-class orexin receptor 2 (OX2R) agonist franchise, with key data readouts expected this year ORX750 Phase 2a CRYSTAL-1 study for the treatment of narcolepsy type 1 (NT1), narcolepsy type 2 (NT2) and idiopathic …
X4 Pharmaceuticals Announces $60 Million Equity Financing with Concurrent Changes in Management and Board Leadership
GlobeNewswire
·
August 12, 2025
$60 million PIPE financing led by Coastlands Capital, Bain Capital Life Sciences and New Enterprise Associates Newly appointed board and management team includes Dr. Adam Craig as Executive Chairman, John Volpone as President and David Kirske as Chief …
Endure Biotherapeutics Receives SBIR Phase I Grant to Advance Engineered Native Bacteria Therapy for Familial Adenomatous Polyposis
GlobeNewswire
·
August 12, 2025
San Diego, Aug. 12, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Endure Biotherapeutics Receives SBIR Phase I Grant to Advance Engineered Native Bacteria Therapy for Familial Adenomatous Polyposis SAN DIEGO – August 12, 2025 – Endure Biotherapeutics, Inc …
TScan Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 12, 2025
Two-year relapse data from ALLOHA™ Phase 1 heme trial to be presented by end of year Expects to dose first solid tumor patients with multiplex TCR-T in the third quarter of 2025 Cash, cash equivalents, and marketable securities continue to fund operations …
Babson College and Vollee Launch MathBot: An Agentic AI Tutor Redefining Business Analytics Education
GlobeNewswire
·
August 12, 2025
WELLESLEY, Mass., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Babson College, a world-renowned leader in entrepreneurial education, has partnered with AI innovation company Vollee (www.vollee.ai) to launch MathBot, an intelligent AI-powered tutor designed to support …
AAVantgarde Bio Announces FDA Fast Track Designation for AAVB-039 for the Treatment of Stargardt Disease
GlobeNewswire
·
August 12, 2025
MILAN, Aug. 12, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced that the U.S. Food and Drug Administration (FDA) has …
Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire
·
August 12, 2025
Clinical Trials of Budoprutug in Immune Thrombocytopenia (ITP) and Systemic Lupus Erythematosus (SLE) Underway; Trial of Budoprutug in Primary Membranous Nephropathy (pMN) Expected to Initiate in the Coming Weeks Budoprutug Subcutaneous Formulation …
Acumen Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
August 12, 2025
Expect to report topline results for ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, in late 2026 Expect decision to advance an oligomer-targeted Enhanced Brain DeliveryTM product candidate in …
Korro Reports Second Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire
·
August 12, 2025
— Interim readout from Phase 1/2a REWRITE clinical trial of KRRO-110 on track for the second half of 2025 — Completed dosing of over 80% of planned REWRITE healthy volunteers across multiple single ascending dose (SAD) cohorts with no treatment emergent …